dr. gorantla on the impact of the aphinity trial in her2 breast cancer
Published 5 years ago • 165 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
7:30
aphinity trial in her2 breast cancer
-
2:11
dr. gogineni on implications of the apt trial in her2 breast cancer
-
1:40
dr. han on the aphinity trial in her2 early-stage breast cancer
-
5:51
the aphinity trial
-
2:31
results of the aphinity trial in her2-positive breast cancer
-
1:39
dr. crew on the aphinity trial results in her2 breast cancer
-
6:01
aphinity trial for her2 breast cancer
-
18:32
usmle ace video 261: breast pathologies - common benign disorders and malignant tumors
-
3:30
the aphinity trial in early-stage her2 breast cancer
-
5:56
aphinity trial: adjuvant her2-targeted therapy in her2 bc
-
4:29
aphinity trial: adjuvant pertuzumab and trastuzumab
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
-
1:10
dr. valdes-albini on the fda approval of adjuvant pertuzumab in her2 breast cancer
-
2:59
the aphinity debate: should we change our treatment of breast cancer?
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
1:15
dr. burstein on the follow-up of apt trial for her2 breast cancer
-
1:31
results of the phase iii aphinity trial in her2-positive breast cancer
-
1:09
dr. gwin on the safety of α-tea plus trastuzumab in recurrent her2 breast cancer
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer